Collectively, these data demonstrate that LY pretreatment suppresses the crosstalk between cancer and stroma through inhibiting the fibroblast activation and interruption of TGF-β1-induced expression of stromal genes important in OC tumors. The gene discussed is TGFB1; the disease is cancer.